Bing Li

Dr. Bing Li

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 April 2024 in Journal of Nanobiotechnology
Verified
Journal Article
Open access
PDF file
LSLingxiang Sun
Lingxiang Sun
YZYifan Zhao
Yifan Zhao
HPHongyi Peng
Hongyi Peng
JZJian Zhou
Jian Zhou
QZQingmei Zhang
Qingmei Zhang
BLBing Li
Bing Li
Carbon dots (CDs) are novel carbon-based nanomaterials that have been used as photosensitizer-mediated photodynamic therapy (PDT) in recent years due to their good photosensitizing activity. Photosensitizers (PSs) are main components of PDT that can produce large amounts of reactive oxygen species (ROS) when stimulated by light source, which have the advantages of low drug resistance and high therapeutic efficiency. CDs can generate ROS efficiently under irradiation and therefore have been extensively studied in disease local phototherapy. In tumor therapy, CDs can be used as PSs or PS carriers to participate in PDT and play an extremely important role. In bacterial infectious diseases, CDs exhibit high bactericidal activity as CDs are effective in disrupting bacterial cell membranes leading to bacterial death upon photoactivation. We focus on recent advances in the therapy of cancer and bacteria with CDs, and also briefly summarize the mechanisms and requirements for PSs in PDT of cancer, bacteria and other diseases. We also discuss the role CDs play in combination therapy and the potential for future applications against other pathogens. Graphical Abstract

18 January 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
RLRan Li
Ran Li
YWYimei Wang
Yimei Wang
JDJie Du
Jie Du
XWXiangyu Wang
Xiangyu Wang
ADAilin Duan
Ailin Duan
BLBing Li
Bing Li
In the present work, we constructed nanoscale graphene oxide (NGO) as a drug nanocarrier to improve the process of tumor-targeted drug releases, promote cellular uptake and accumulation of chemotherapy drugs in tumor tissues, and reduce the toxic effects of chemotherapy drugs on normal cells. Hence, great stability was obtained in the biological solution. Moreover, we designed an effective nanoparticle system for the doxorubicin (DOX) delivery targeting the oral squamous cell carcinoma (OSCC) by mediating the HN-1 (TSPLNIHNGQKL) through hydrogen and π–π bonds. DOX@NGO-PEG-HN-1 showed significantly higher cellular uptakes and cytotoxicity in OSCC cells (CAL-27 and SCC-25), compared to free DOX. Moreover, HN-1 showed considerable tumor-targeting and competition inhibition phenomenon. As we expected, the nanocarrier showed pH-responsive drug release. In total, our study represented a good technique to construct OSCC-targeted delivery of nanoparticles and improve the anticancer medicines’ efficiency.

29 September 2023 in Carbohydrate Polymers
Verified
Journal Article
Closed access
YLYingyu Liu
Yingyu Liu
HLHaiyan Liu
Haiyan Liu
SGSusu Guo
Susu Guo
YZYifan Zhao
Yifan Zhao
JQJin Qi
Jin Qi
BLBing Li
Bing Li

19 May 2023 in ACS Applied Nano Materials
Verified
Journal Article
Closed access
JQJin Qi
Jin Qi
RZRan Zhang
Ran Zhang
XLXiaoming Liu
Xiaoming Liu
YLYingyu Liu
Yingyu Liu
QZQingmei Zhang
Qingmei Zhang
BLBing Li
Bing Li

1 June 2023 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
RLRan Li
Ran Li
CLChen Liu
Chen Liu
CWChaoqiong Wan
Chaoqiong Wan
TLTiantian Liu
Tiantian Liu
RZRongrong Zhang
Rongrong Zhang
BLBing Li
Bing Li
Purpose: Oral squamous cell carcinoma (OSCC) is a malignant disease with serious impacts on human health and quality of life worldwide. This disease is traditionally treated through a combination of surgery, radiotherapy, and chemotherapy. However, the efficacy of traditional treatments is hindered by systemic toxicity, limited therapeutic effects, and drug resistance. Fibroblast activation protein (FAP) is a membrane-bound protease. Although FAP has limited expression in normal adult tissues, it is highly expressed in the tumor microenvironment of many solid cancers – a characteristic that makes it an ideal target for anticancer therapy. In this study, we constructed a nano-drug delivery system ([email protected]) targeting FAP to increase the therapeutic efficiency of synergistic chemo-photothermal therapy against OSCC. Methods: We utilized PEGylated nano-graphene oxide (NGO) to link doxorubicin (DOX) and fluorescently-labeled, FAP-targeted peptide chains via hydrogen bonding and π–π bonding to enhance the targeting capability of [email protected] The synthesis of [email protected] was analyzed using UV–Vis and FT–IR spectroscopy and its morphology using transmission electron microscopy (TEM). Additionally, the drug uptake efficiency in vitro, photo-thermal properties, release performance, and anti-tumor effects of [email protected] were evaluated and further demonstrated in vivo. Results: Data derived from FT–IR, UV–Vis, and TEM implied successful construction of the [email protected] nano-drug delivery system. Confocal laser scanning microscopy images and in vivo experiments demonstrated the targeting effects of FAP on OSCC. Furthermore, [email protected] exhibited a high photothermal conversion efficiency (52.48%) under near-infrared radiation. The thermogenic effect of [email protected] simultaneously promoted local release of DOX and apoptosis based on a pH-stimulated effect. Importantly, FAP-targeted [email protected] in combination with PTT showed better tumor suppression performance in vivo and in vitro than did either therapy individually. Conclusion: [email protected] can precisely target OSCC, and combined treatment with chemical and photothermal therapy can improve the therapeutic outcomes of OSCC. This method serves as an efficient therapeutic strategy for the development of synergistic anti-tumor research.

26 August 2024 in Carbohydrate Polymers
Verified
Journal Article
Closed access
YLYingyu Liu
Yingyu Liu
YZYifan Zhao
Yifan Zhao
SGSusu Guo
Susu Guo
DQDanlei Qin
Danlei Qin
JYJingyu Yan
Jingyu Yan
BLBing Li
Bing Li